Visalytics
Visalytics
approved EB-1A RFE Issued

Biostatistician II

Epidemiology · China · 2025-07-01

Processing Time
503 days
Decision Date
2025-07-01
Location
Kansas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Original Scientific Contributions of Major Significance (Met)

The petitioner improved predictive modeling in epidemiology and clarified the efficacy of antithrombotic therapy in COVID-19 patients, with work cited extensively by other researchers.

Authorship in Scholarly Publications (Met)

The petitioner authored landmark studies on dietary risk factors and cancer risks in prestigious journals, with multiple articles being among the most highly cited in the field.

Judging the Work of Others (Met)

The petitioner served as a peer reviewer for high-impact journals such as the Journal of Ovarian Research and Frontiers in Nutrition.

Why This Petition Was Approved

The petition was approved based on 25 peer-reviewed publications and one book chapter in high-impact journals like NEJM and JAMA, which garnered over 2,800 citations from 70 countries. The petitioner satisfied three EB-1A criteria: original scientific contributions, scholarly authorship, and judging the work of others. Additionally, the work was supported by funding from prominent agencies such as the NIH and NCI.

Request for Evidence (RFE)

Successfully Addressed

USCIS issued a Request for Evidence during the adjudication process. The legal team provided timely and compelling clarifications that successfully addressed the concerns, leading to approval.

RFE Targets
Original Scientific Contributions of Major SignificanceAuthorship in Scholarly PublicationsJudging the Work of Others

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Evidence Submitted
  • 25 peer-reviewed publications
  • 1 book chapter
  • Over 2,800 citations from researchers in more than 70 countries
  • Publications in top-tier journals including The New England Journal of Medicine, JAMA, and Annals of Internal Medicine
  • Peer review service for journals including Journal of Ovarian Research and Frontiers in Nutrition
  • Research funding from NIH and NCI

Similar Cases

Researcher

Healthcare · United Arab Emirates

WeGreened EB-1A rfe approved
Virginia 116 days 2025-06-09
The petitioner satisfied three EB-1A criteria: original contributions of major significance, authorship of scholarly articles, and participation as a judge of others' work. Evidence included 18 peer-reviewed publications in top journals like The Lancet and over 200 citations from 37 countries. Additionally, the petitioner completed 18 manuscript reviews and serves on an editorial board.
View Case

Postdoctoral Researcher

Biotechnology · Bangladesh

WeGreened EB-1A approved
Massachusetts 14 days 2025-05-21
The petition was approved based on a scholarly portfolio of 15 peer-reviewed publications in top-tier journals like Nature Methods and PNAS, which garnered 254 citations. The petitioner demonstrated professional standing through over 18 peer reviews for high-impact journals and service on editorial boards. Additionally, the research attracted funding from prestigious bodies including the NIH, NSF, and National Cancer Institute.
View Case

Postdoctoral Researcher

Biotechnology · Brazil

WeGreened EB-1A rfe approved
Maryland 98 days 2025-06-25
The petition was approved based on a record of 27 peer-reviewed publications in journals like Journal of Hepatology and Molecular Cell. The petitioner demonstrated impact through 255 citations from researchers in over 30 countries and the completion of at least 15 peer reviews. The evidence satisfied the EB-1A criteria for scholarly articles, judging, and original contributions of major significance.
View Case

Professor

Healthcare · Poland

WeGreened EB-1A approved
Poland 10 days 2025-07-05
The petitioner submitted evidence of over 200 peer-reviewed journal articles in top-tier venues like JAMA and EuroIntervention, which garnered more than 3,600 citations. Additionally, the petitioner demonstrated a significant record of judging the work of others through over 140 peer reviews for journals such as The Lancet. The case successfully satisfied three EB-1A criteria: scholarly articles, judging, and original contributions of major significance.
View Case

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 503 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Related Pages

EB-1A Overview EB-1A in China All EB-1A Cases EB-1A Dashboard

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist